Psychometric characteristics of the Czech version of the Brief Symptom inventory (BSI-53)

被引:0
作者
Kabat, Jaromir [1 ,2 ]
Kascakova, Natalia [1 ,4 ]
Furstova, Jana [1 ]
Bartuskova, Ludmila [1 ,3 ]
Glogar, Petr [1 ]
Solcova, Iva Polackova [5 ]
Tavel, Peter [1 ]
机构
[1] Univ Palackeho Olomouci, Inst Socialniho Zdravi, Univ 244-22, Olomouc 77111, Czech Republic
[2] Psychosomat Klin Sro, Prague, Czech Republic
[3] Denni Psychoterapeut Sanat Ondrejov Sro, Prague, Czech Republic
[4] Pro Mente Sana, Psychiat Psychoterapeut Prax, Bratislava, Slovakia
[5] Univ Karlova, Fak Humanitnich Studii, Prague, Czech Republic
来源
CESKOSLOVENSKA PSYCHOLOGIE | 2018年 / 62卷
关键词
psychopathological symptoms; confirmatory factor analysis; BSI-53; SCL-90; SF-8; FACTORIAL STRUCTURE; COMMUNITY NORMS; VALIDITY; RELIABILITY; DEPRESSION; SCL-90; ADULT; QUESTIONNAIRE; SAMPLE;
D O I
暂无
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Objectives. Assessment of psychopathological symptoms is an important part of research and clinical practice. This study examines the psychometric characteristics of the Czech version of the Brief Symptom Inventory (BSI-53 CZ) and forms the basis for creating standards for the Czech non-clinical population. The BSI-53 is a shorter, multidimensional version of the Symptom-Checklist 90-R (SCL 90-R) questionnaire used to detect the presence of psychopathological symptoms. The instrument contains nine subscales and three general indexes: the Global Severity Index (GSI), Positive Symptom Total (PST) and Positive Symptom Distress Index (PSDI). Sample and settings. A cross-sectional study on a representative sample of the adult Czech population (N=1800, mean age 46.4, SD 17.4, 48.7% men). Statistical analyses were performed on the collected BSI-53 data. The Short-Form Health Survey (SF-8) was used to determine the convergent validity. Results. Spearnian's correlation coefficients between the BSI-53 subscales are moderately high, with values of 0.45-0.75. Confirmatory factor analysis for a standard nine-factor model showed that loadings of all items on the associated factors were medium to high, with values of 0.55-0.87. This model shows a sufficient fit to our data: chi(2) (1091)=4328.2, p<0.001, CFI=0.994, 111=0.994, SRMR=0.045, RMSEA=0.041 (90%CI=0.039-0.042). Internal consistency of the BSI-53 is high, with Cronbach's alpha=0.97 (95%Cl 0.97-0.98) and McDonald coefficients omega(h) =0.84 and omega(t) =0.97. The convergent validity, assessed by correlations with the mental health subscale of the SF-8 questionnaire, was found to be moderate to high. Significant differences in the occurrence of psychopathological symptoms among different sociodemographic groups of the Czech population were found. Differences between the Czech data and data from several foreign countries (Gennany, Cmat Britain and Israel) were found. Conclusion. The BSI-53 questionnaire is a short, reliable instrument for the assessment of psychological distress. The degree of utility of the instrument in clinical work and the evaluation of its potential to identify specific clinical syndromes and sensitivity to detect changes should be documented by further studies.
引用
收藏
页码:19 / 39
页数:21
相关论文
共 54 条
  • [1] [Anonymous], 2000, MANUAL G TTINGEN BEL
  • [2] Psychological treatment outcomes in routine NHS services: What do we mean by treatment effectiveness?
    Barkham, Michael
    Stiles, William B.
    Connell, Janice
    Mellor-Clark, John
    [J]. PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, 2012, 85 (01) : 1 - 16
  • [3] Somatic symptom reporting in women and men
    Barsky, AJ
    Peekna, HM
    Borus, JF
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (04) : 266 - 275
  • [4] Bartusková L, 2018, CESK PSYCHOL, V62, P40
  • [5] Exploratory and confirmatory factor analyses of the brief symptom inventory among substance abusers
    Benishek, LA
    Hayes, CM
    Bieschke, KJ
    Stöffelmayr, BE
    [J]. JOURNAL OF SUBSTANCE ABUSE, 1998, 10 (02) : 103 - 114
  • [6] Biescad M, 2006, PSYCHIATRIA, V13, P25
  • [7] BOLELOUCKY Z, 1989, ACTIV NERV SUPER, V31, P122
  • [8] BOLELOUCKY Z, 1974, ACTIV NERV SUPER, V16, P115
  • [9] CANETTI L, 1994, ISRAEL J PSYCHIAT, V31, P13
  • [10] Cote S, 1996, INT J PSYCHOL, V31, P84113